Amerisource Cuts $625M FCA Deal Over Repacked Drugs

By Dorothy Atkins (November 22, 2017, 3:17 PM EST) -- Pharmaceutical giant AmerisourceBergen Corp. has struck a $625 million deal to settle the government's False Claims Act investigation into the drug wholesaler's practice of repackaging and selling injectable drugs, allegedly without regard to product purity, according to documents filed with U.S. securities regulators Tuesday....

Law360 is on it, so you are, too.

A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.

A Law360 subscription includes features such as

  • Daily newsletters
  • Expert analysis
  • Mobile app
  • Advanced search
  • Judge information
  • Real-time alerts
  • 450K+ searchable archived articles

And more!

Experience Law360 today with a free 7-day trial.

Start Free Trial

Already a subscriber? Click here to login

Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Ask a question!